Predictive test for identification of early stage nsclc patients at high risk of recurrence after surgery
US2021118538A1
Apparatus and method for identification of primary immune resistance in cancer patients
US10422729B1
Blood sample separation devices and methods
WO2019079635A1
Compositions, methods and kits for diagnosis of lung cancer
US2019353645A1
Method for Identification of Cancer Patients with Durable Benefit from Immunotherapy in Overall Poor Prognosis Subgroups
US2018202005A1
Diagnostic test system for specific, sensitive and reproducible detection of circulating nucleic acids in whole blood
US2018059113A1
Compositions, methods and kits for diagnosis of lung cancer
WO2017176423A1
Classifier generation methods and predictive test for ovarian cancer patient prognosis under platinum chemotherapy
US2019018929A1
Predictive Test for Melanoma Patient Benefit from Interleukin-2 (IL2) Therapy
US2017039345A1
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
WO2016175990A1
Bagged filtering method for selection and deselection of features for classification
US9563744B1
Method of predicting development and severity of graft-versus-host disease
WO2016089553A1
Early detection of hepatocellular carcinoma in high risk populations using maldi-tof mass spectrometry
WO2016054031A1
Predictive test for aggressiveness or indolence of prostate cancer from mass spectrometry of blood-based sample
US2015285817A1
Method for treating and identifying lung cancer patients likely to benefit from EGFR inhibitor and a monoclonal antibody HGF inhibitor combination therapy
AU2014318499A1
Classifier generation method using combination of mini-classifiers with regularization and uses thereof
WO2015178946A1
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
AU2013287262A1
Method for predicting whether a cancer patient will not benefit from platinum-based chemotherapy agents
CA2878044A1
Mass-spectral method for selection, and de-selection, of cancer patients for treatment with immune response generating therapies
WO2013180818A2
Deep-maldi tof mass spectrometry of complex biological samples, e.g., serum, and uses thereof
